Access the full text.
Sign up today, get DeepDyve free for 14 days.
M. Popovič, M. Sarngadharan, E. Read, R. Gallo (1984)
Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.Science, 224 4648
A. Billich, F. Hammerschmid, P. Peichl, R. Wenger, G. Zenke, V. Quesniaux, B. Rosenwirth (1995)
Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: interference with HIV protein-cyclophilin A interactionsJournal of Virology, 69
Melissa McCornack, L. Kakalis, Carlo Caserta, R. Handschumacher, I. Armitage (1997)
HIV protease substrate conformation: modulation by cyclophilin AFEBS Letters, 414
D. Braaten, C. Aberham, E. Franke, Lei Yin, W. Phares, J. Luban (1996)
Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin AJournal of Virology, 70
K. Nagy, Michael Young, C. Baboonian, J. Merson, P. Whittle, S. Oroszlan (1994)
Antiviral activity of human immunodeficiency virus type 1 protease inhibitors in a single cycle of infection: evidence for a role of protease in the early phaseJournal of Virology, 68
Abraham Karpas, Mark Lowdell, S. Jacobson, F. Hill (1992)
Inhibition of human immunodeficiency virus and growth of infected T cells by the immunosuppressive drugs cyclosporin A and FK 506.Proceedings of the National Academy of Sciences of the United States of America, 89 17
C. DeLuca, A. Roulston, A. Koromilas, M. Wainberg, J. Hiscott (1996)
Chronic human immunodeficiency virus type 1 infection of myeloid cells disrupts the autoregulatory control of the NF-kappaB/Rel pathway via enhanced IkappaBalpha degradationJournal of Virology, 70
Brigitte Rosenwirth, Andreas Billich, Roelf Datema, Peter Donatsch, F. Hammerschmid, Richard Harrison, Peter Hiestand, Herbert Jaksche, '. Mayer, Peter Peichl, '. Quesniaux, Franz Schatz, Henk-Jan Schuurman, Rene Traber, Roland Wenger, Barbara Wolff, Gerhard Zenke (1994)
Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analogAntimicrobial Agents and Chemotherapy, 38
E. Franke, H. Yuan, J. Luban (1994)
Specific incorporation of cyclophilin A into HIV-1 virionsNature, 372
(1990)
The retroviral proteinase
M. MacArthur, M. MacArthur, J. Thornton (1991)
Influence of proline residues on protein conformation.Journal of molecular biology, 218 2
D. Ott (1997)
Cellular proteins in HIV virionsReviews in Medical Virology, 7
D. Fruman, S. Burakoff, B. Bierer (1994)
Immunophilins in protein folding and immunosuppression 1The FASEB Journal, 8
J. Luban, K. Bossolt, E. Franke, G. Kalpana, S. Goff (1993)
Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and BCell, 73
D. Ott, L. Coren, Donald Johnson, R. Sowder, L. Arthur, L. Henderson (1995)
Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain.AIDS research and human retroviruses, 11 9
D. Braaten, E. Franke, J. Luban (1996)
Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcriptionJournal of Virology, 70
M. Thali, A. Bukovsky, E. Kondo, Brigitte Rosenwlrth, C. Walsh, J. Sodroski, H. Göttlinger (1994)
Functional association of cyclophilin A with HIV-1 virionsNature, 372
J. Vance, D. Leblanc, P. Wingfield, R. London (1997)
Conformational Selectivity of HIV-1 Protease Cleavage of X-Pro Peptide Bonds and Its Implications*The Journal of Biological Chemistry, 272
J. Tözsér, I. Weber, A. Gustchina, I. Bláha, T. Copeland, J. Louis, S. Oroszlan (1992)
Kinetic and modeling studies of S3-S3' subsites of HIV proteinases.Biochemistry, 31 20
C. Aberham, Sabine Weber, William Phares (1996)
Spontaneous mutations in the human immunodeficiency virus type 1 gag gene that affect viral replication in the presence of cyclosporinsJournal of Virology, 70
C. Briggs, J. Tözsér, S. Oroszlan (1996)
Effect of cyclosporin A on the replication cycle of human immunodeficiency virus type 1 derived from H9 and Molt-4 producer cells.The Journal of general virology, 77 ( Pt 12)
R. Harrison, R. Stein (1990)
Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes.Biochemistry, 29 16
K. Nye, A. Pinching (1990)
HIV infection of H9 lymphoblastoid cells chronically activates the inositol polyphosphate pathway.AIDS, 4 1
Sudhir Gupta, B. Vayuvegula (1987)
Human immunodeficiency virus-associated changes in signal transductionJournal of Clinical Immunology, 7
J. Kimpton, M. Emerman (1992)
Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase geneJournal of Virology, 66
The presence of FK506-binding protein-12 was demonstrated in virions of HIV-1, although its concentration was lower than that of cyclophilin A. The effect of two inhibitors of the peptidyl-prolyl cis - trans isomerases FK506 and cyclosporin A (CsA) was studied in H9 cells that were chronically infe- cted by HIV-1. Both drugs inhibited virus production in the infected cells in a concentration-dependent manner, by decreasing the number of the producing cells. FK506 did not have an effect on Gag processing, based on the p24 antigen content of virions produced in the presence of this drug. Furthermore, FK506 treatment of uninfected H9 cells did not diminish their susceptibility toward HIV-1 infection, whereas CsA treatment decreased the degree of HIV-1 infection with an IC 50 of 1–2 μg/ml. Also, pretreatment of the virus with CsA decreased its infectivity in HeLaCD4-LTR/β-gal cells; in contrast, at concentrations up to 10 μg/ml, FK506 did not have an effect. Our findings on the antiviral activity of FK506 and CsA suggest that FK506 is effective only in chronically infected cells, by selectively inhibiting the growth of HIV-1 infected cells, whereas CsA has a specific effect on virus replication.
Archives of Virology – Springer Journals
Published: Nov 1, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.